What Is Nephros, Inc. (NEPH) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Nephros, Inc.'s intrinsic value is estimated at $1.87, suggesting the stock is overvalued at its current price of $3.55. With 11 out of 12 models flagging downside (-47.4% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: First Chicago targets $5.20 (+46.5%), versus Bayesian DCF at $0.42 (-88.1%). This +134.6% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About NEPH?
12 of 13 models are currently active for NEPH. Of these, 1 model suggests upside while 11 models suggest overvaluation. The Bayesian DCF estimates NEPH's intrinsic value at $0.42, implying -88.1% downside from the current price. See which stocks rank higher →
How Does NEPH Rank in Surgical & Medical Instruments & Apparatus?
Among 117 Surgical & Medical Instruments & Apparatus stocks, NEPH ranks #27 by Quality of Company score. CirclFi's QOC score of 7.7/10 evaluates 32 fundamental signals. A score of 7.7 indicates above-average quality.
See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →
Nephros, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is NEPH a Value Trap?
CirclFi's Value Trap algorithm assigns NEPH a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Nephros, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Nephros, Inc.'s fundamental quality profile registers 7.7/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +134.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every NEPH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across NEPH's 12 active models, average confidence is 38%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad